Absorption and disposition of a tripeptoid and a tetrapeptide in the rat

Biopharmaceutics and Drug Disposition

Volumn 20, Issue 2, 1999, Pages 69-75

  Wang, Yanfeng ^a,b   Lin, Hanford ^a   Tullman, Robert ^a   Jewell Jr , Charles F ^a   Weetall, Maria L ^a   Tse, Francis L S ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Absorption; Absorptive clearance; Disposition; Peptide; Peptoid; Permeability

Indexed keywords

GLYCINE DERIVATIVE; OCTANOL; TETRAPEPTIDE; TRIPEPTIDE; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILIARY EXCRETION; CHEMICAL STRUCTURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG ELIMINATION; DRUG FECES LEVEL; DRUG METABOLISM; DRUG URINE LEVEL; INTESTINE ABSORPTION; INTESTINE PERFUSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PARTITION COEFFICIENT; RAT;

ADMINISTRATION, ORAL; ANIMALS; GLYCINE; INTESTINAL ABSORPTION; MALE; OLIGOPEPTIDES; PEPTOIDS; RATS; RATS, SPRAGUE-DAWLEY; STRUCTURE-ACTIVITY RELATIONSHIP; TISSUE DISTRIBUTION; TRITIUM;

EID: 0033001784     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-081X(199903)20:2<69::AID-BDD153>3.0.CO;2-B     Document Type: Article

References (15)

1. B.J. Aungst, Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. J. Pharm. Sci., 82, 979-987 (1993).
2. R.J. Simon, R.S. Kania, R.N. Zuckermann, V.D. Huebner, D.A. Jewell, S. Banville, S. Ng, L. Wang, S. Rosenberg, C.K. Marlowe, D.C. Spellmeyer, R. Tan, A.D. Frankel, D.V. Santi, F.E. Cohen and P.A. Bartlett, Peptoids: A modular approach to drug discovery. Proc. Natl. Acad. Sci. USA, 89, 9367-9371 (1992).
3. S.M. Miller, R.J. Silmon, S. Ng, R.N. Zuckermann, J.M. Kerr and W.H. Moos, Proteolytic studies of homologous peptide and N-substituted glycine peptoid oligomers. Bioorg. Med. Chem. Let., 4, 2657-2662 (1994).
4. R.A. Conradi, A.R. Hilgers, N.F.H. Ho and P.S. Burton, The influence of peptide structure on transport across Caco-2 cells. II. Peptide bond modification which results in improved permeability. Pharm. Res., 9, 435-439 (1992).
5. S. Molossi, M. Elices, T. Arrhemius, R. Diaz, C. Coulber and M. Rabinovitch, Blockade of very late antigen-4 integrin binding to fibronectin with connecting segment-1 peptide reduces accelerated coronary arteriopathy in rabbit cardiac allografts. J. Clin. Invest., 95, 2601-2610 (1995).
6. A. Komoriya, L. Green, M. Mervic, S., Yamada, K. Yamada and M. Humphries, The minimal essential sequence for major cell type-specific adhesion site (CS-1) within the alternatively spliced type III connecting segment domain of fibronectin is leucin-aspartic acid-valine. J. Biol. Chem., 266, 15075-15079 (1991).
7. E.A. Wayner, A. garcia-Pardo, M.J. Humphries, J.A. MacDonald and W.G. Carter, Identification and characterization of the T-lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J. Cell Biol., 109, 1321-1330 (1989).
8. R.N. Zuckermann, E.J. Martin, D.C. Spellmeyer and W.H. Moos, Discovery of nanomolar ligands for 7-transmembrane G-protein-coupled receptors from a diverse N-(substituted) glycine peptoid library. J. Med. Chem., 37, 2678 (1994).
9. Y. Wang, R. Aun and F.L.S. Tse, Absorption of n-glucose in the rat studied using in situ intestinal perfusion: A permeability index approach. Pharm. Res., 14, 1563-1567 (1997).
10. L.E. Riad and R. Sawchuk, Absorptive clearance of carbamazepine and selected metabolites in rabbit intestine. Pharm. Res., 8, 1050-1055 (1991).
11. W.D. Stein, The molecular basis of diffusion across cell membranes. In The Movement of Molecules Across Cell Membranes, Academic Press, New York, 1967, Chapter 3, pp. 65-125.
12. O.H. Chan and B.H. Stewart, Physicochemical and drug delivery considerations for oral drug bioavailability. Drug. Disc. Today, 1, 461-473 (1996).
13. B.H. Stewart, O.H. Chan, R.H. Lu, E.L. Reyner, H.L. Schmid, H.W. Hamilton, B.A. Steinbaugh and M.D. Taylor, Comparison of intestinal permeabilities determined in multiple in vitro and in situ models: relationship to absorption in humans. Pharm. Res., 12, 693-699 (1995).
14. G.L. Amidon, P.J. Sinko and D. Fleisher, Estimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds. Pharm. Res., 5, 651-654 (1988).
15. U. Fagerholm, M. Johansson and H. Lennernas, Comparison between permeability coefficients in rat and human jejunum. Pharm. Res., 13, 1336-1342 (1996).